4th Quarter - Report

CROSSROADS STRATEGIES, LLC for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.1, Tax Cuts and Jobs Act (P.L.115-97); issues related to tax reform.

LobbyistCovered position, as disclosed
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1 (115th)

Health Issues HCR

Implementation of P.L.114-255, 21st Century Cures Act. S.204/H.R.878, Trickett Wendler Right to Try Act of 2017. H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program and truthful non-misleading industry communications.

LobbyistCovered position, as disclosed
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB); Executive Office of the President (EOP)

Bills named: S. 204 (115th), H.R. 878 (115th), H.R. 1628 (115th)

Medicare/Medicaid MMM

General issues related to Medicare and Medicaid, including: Part D Medicare program, IPAB repeal and Medicare Part B reimbursement.

LobbyistCovered position, as disclosed
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Executive Office of the President (EOP)

Budget/Appropriations BUD

H.R.3268/S.1603, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; H.J.Res.123, Making further continuing appropriations for fiscal year 2018, and for other purposes (P.L.115-90); H.J.Res.124, Making further additional continuing appropriations for fiscal year 2018, and for other purposes; H.R.1370, Further Additional Continuing Appropriations Act, 2018 (P.L.115-96); Food and Drug Administration (FDA) related issues.

LobbyistCovered position, as disclosed
SHAY MICHAEL HANCOCK —
MATHEW LAPINSKI —
HUNTER MOORHEAD —
JASON BENJAMIN VAN PELT —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1370 (115th), S. 1603 (115th), H.R. 3268 (115th), H.J.Res. 123 (115th), H.J.Res. 124 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.